Weekly paclitaxel vs three‐weekly paclitaxel
Quality of life ‐ not reported · women with recurrent epithelial ovarian cancer
The review found no eligible studies for this question.
1 finding from 1 review
- Taxane monotherapy regimens for the treatment of recurrent epithelial ovarian cancer 2022 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found